doi: 10.1097/INF.0b013e3181c81fd4.
Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen
Affiliations
- PMID: 19949355
- DOI: 10.1097/INF.0b013e3181c81fd4
Item in Clipboard
Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen
Pediatr Infect Dis J.
2010 Apr.
Abstract
Recent updates of the guidelines on the prevention of human immunodeficiency virus mother-to-child transmission have shortened the neonatal zidovudine prophylactic regimens from 6 to 4 weeks. We present a prospective observational study in a large cohort of mother-infant pairs and report that the 4-week regimen allows an earlier recovery of the anemia in these otherwise healthy infants.
Similar articles
-
A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.Clin Infect Dis. 2007 Jan 1;44(1):111-9. doi: 10.1086/508869. Epub 2006 Nov 22. Clin Infect Dis. 2007. PMID: 17143826 Clinical Trial.
-
Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?J Trop Pediatr. 2006 Aug;52(4):235-8. doi: 10.1093/tropej/fml033. J Trop Pediatr. 2006. PMID: 16877674 Review. No abstract available.
-
A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.J Infect Dis. 2003 Mar 1;187(5):725-35. doi: 10.1086/367898. Epub 2003 Feb 24. J Infect Dis. 2003. PMID: 12599045 Clinical Trial.
-
HIV-1 drug resistance and mother-to-child transmission.SADJ. 2001 Dec;56(12):614-6. SADJ. 2001. PMID: 11887450 Review.
-
A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators.N Engl J Med. 2000 Oct 5;343(14):982-91. doi: 10.1056/NEJM200010053431401. N Engl J Med. 2000. PMID: 11018164 Clinical Trial.
Cited by
-
HIV/Tuberculosis Coinfection in Pregnancy and the Postpartum Period.J Clin Med. 2023 Sep 29;12(19):6302. doi: 10.3390/jcm12196302. J Clin Med. 2023. PMID: 37834946 Free PMC article. Review.
-
Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study.J Antimicrob Chemother. 2023 Jul 5;78(7):1711-1722. doi: 10.1093/jac/dkad161. J Antimicrob Chemother. 2023. PMID: 37248782 Free PMC article. Clinical Trial.
-
HIV Prophylaxis in High Risk Newborns: An Examination of Sociodemographic Factors in an Inner City Context.Can J Infect Dis Med Microbiol. 2016;2016:2782786. doi: 10.1155/2016/2782786. Epub 2016 Apr 3. Can J Infect Dis Med Microbiol. 2016. PMID: 27366161 Free PMC article.
-
Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants.Eur J Pediatr. 2016 Jul;175(7):1013-7. doi: 10.1007/s00431-016-2730-x. Epub 2016 May 10. Eur J Pediatr. 2016. PMID: 27165499
-
Paediatric HIV: Progress on Prevention, Treatment and Cure.Curr Pediatr Rep. 2015 Sep;3(3):219-229. doi: 10.1007/s40124-015-0087-7. Epub 2015 Jul 22. Curr Pediatr Rep. 2015. PMID: 26709366 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
